HarbourVest, Pantheon enable $1.1bn continuation fund for QHP Capital’s Azurity Pharmaceuticals

QHP Capital has hit a $1.1bn final close for a single-asset continuation vehicle for its portfolio business Azurity Pharmaceuticals.